St-Onge, M. P. et al. Sleep duration and quality: Impact on lifestyle behaviors and cardiometabolic health: A scientific statement from the American heart association. Circulation 134, e367–e386 (2016).
Tsao, C. W. et al. Heart disease and stroke statistics-2022 update: A report from the American heart association. Circulation 145, e153–e639 (2022).
Makarem, N. et al. Redefining cardiovascular health to include sleep: Prospective associations with cardiovascular disease in the MESA sleep study. J. Am. Heart Assoc. 11, e025252 (2022).
Ferrie, J. E. et al. A prospective study of change in sleep duration: Associations with mortality in the Whitehall II cohort. Sleep 30, 1659–1666 (2007).
Ayas, N. T. et al. A prospective study of sleep duration and coronary heart disease in women. Arch. Intern. Med. 163, 205–209 (2003).
Cappuccio, F. P. et al. Gender-specific associations of short sleep duration with prevalent and incident hypertension: The Whitehall II Study. Hypertension 50, 693–700 (2007).
Shah, R. et al. Sleep deprivation impairs vascular function in healthy women: A clinical trial. Ann. Am. Thorac. Soc. 19, 2097–2100 (2022).
Covassin, N. et al. Effects of experimental sleep restriction on ambulatory and sleep blood pressure in healthy young adults: A randomized crossover study. Hypertension 78, 859–870 (2021).
Gloire, G., Legrand-Poels, S. & Piette, J. NF-kappaB activation by reactive oxygen species: Fifteen years later. Biochem. Pharmacol. 72, 1493–1505 (2006).
Pennathur, S. & Heinecke, J. W. Oxidative stress and endothelial dysfunction in vascular disease. Curr. Diab. Rep. 7, 257–264 (2007).
Vaccaro, A. et al. Sleep loss can cause death through accumulation of reactive oxygen species in the gut. Cell 181, 1307–1328 (2020).
Williams, M. J. et al. Recurrent sleep fragmentation induces insulin and neuroprotective mechanisms in middle-aged flies. Front. Aging Neurosci. 8, 180 (2016).
Nikonova, E. V. et al. Changes in components of energy regulation in mouse cortex with increases in wakefulness. Sleep 33, 889–900 (2010).
Silva-Islas, C. A. & Maldonado, P. D. Canonical and non-canonical mechanisms of Nrf2 activation. Pharmacol. Res. 134, 92–99 (2018).
Chen, X. L. et al. Activation of Nrf2/ARE pathway protects endothelial cells from oxidant injury and inhibits inflammatory gene expression. Am. J. Physiol. Heart Circ. Physiol. 290, H1862-1870 (2006).
Zhang, D. D. Mechanistic studies of the Nrf2-Keap1 signaling pathway. Drug Metab. Rev. 38, 769–789 (2006).
Hill, V. M. et al. A bidirectional relationship between sleep and oxidative stress in Drosophila. PLoS Biol. 16, e2005206 (2018).
Skinner, N. & Dorrian, J. A work-life perspective on sleep and fatigue–looking beyond shift workers. Ind. Health 53, 417–426 (2015).
Emin, M. et al. Increased internalization of complement inhibitor CD59 may contribute to endothelial inflammation in obstructive sleep apnea. Sci. Transl. Med. 8, 320–321 (2016).
Onat, D. et al. Vascular endothelial sampling and analysis of gene transcripts: A new quantitative approach to monitor vascular inflammation. J. Appl. Physiol. 1985(103), 1873–1878 (2007).
Aggarwal, B. et al. Effects of inadequate sleep on blood pressure and endothelial inflammation in women: Findings from the American heart association go red for women strategically focused research network. J. Am. Heart Assoc. 7, e008590 (2018).
Li, L. C. et al. MDG-1 inhibits H2O2-induced apoptosis and inflammation in human umbilical vein endothelial cells. Mo. l Med. Rep. 16, 3673–3679 (2017).
Silver, A. E. et al. Overweight and obese humans demonstrate increased vascular endothelial NAD(P)H oxidase-p47(phox) expression and evidence of endothelial oxidative stress. Circulation 115, 627–637 (2007).
Antoniades, C. et al. 5-methyltetrahydrofolate rapidly improves endothelial function and decreases superoxide production in human vessels: Effects on vascular tetrahydrobiopterin availability and endothelial nitric oxide synthase coupling. Circulation 114, 1193–1201 (2006).
Mayer, K. et al. Diphthamide affects selenoprotein expression: Diphthamide deficiency reduces selenocysteine incorporation, decreases selenite sensitivity and pre-disposes to oxidative stress. Redox. Biol. 20, 146–156 (2019).
Lungato, L. et al. Sleep deprivation alters gene expression and antioxidant enzyme activity in mice splenocytes. Scand. J. Immunol. 77, 195–199 (2013).
Ramanathan, L., Hu, S., Frautschy, S. A. & Siegel, J. M. Short-term total sleep deprivation in the rat increases antioxidant responses in multiple brain regions without impairing spontaneous alternation behavior. Behav. Brain Res. 207, 305–309 (2010).
Iso, T., Suzuki, T., Baird, L. & Yamamoto, M. Absolute amounts and status of the Nrf2-Keap1-Cul3 complex within cells. Mol. Cell. Biol. 36, 3100–3112 (2016).
Furukawa, M. & Xiong, Y. BTB protein Keap1 targets antioxidant transcription factor Nrf2 for ubiquitination by the Cullin 3-Roc1 ligase. Mol. Cell Biol. 25, 162–171 (2005).
Stark, C. et al. BioGRID: A general repository for interaction datasets. Nucl. Acids Res. 34, D535-539 (2006).
Meyer-Schaller, N. et al. The human Dcn1-like protein DCNL3 promotes Cul3 neddylation at membranes. Proc. Natl. Acad. Sci. USA 106, 12365–12370 (2009).
Ma, T. et al. DCUN1D3, a novel UVC-responsive gene that is involved in cell cycle progression and cell growth. Cancer Sci. 99, 2128–2135 (2008).
Fornes, O. et al. JASPAR 2020: update of the open-access database of transcription factor binding profiles. Nucl. Acids Res. 48, D87–D92 (2020).
Vickers, E. R. et al. Ternary complex factor-serum response factor complex-regulated gene activity is required for cellular proliferation and inhibition of apoptotic cell death. Mol. Cell Biol. 24, 10340–10351 (2004).
Ramanan, N. et al. SRF mediates activity-induced gene expression and synaptic plasticity but not neuronal viability. Nat. Neurosci. 8, 759–767 (2005).
Hor, C. N. et al. Sleep-wake-driven and circadian contributions to daily rhythms in gene expression and chromatin accessibility in the murine cortex. Proc. Natl. Acad. Sci. USA 116, 25773–25783 (2019).
Donlea, J. M., Ramanan, N. & Shaw, P. J. Use-dependent plasticity in clock neurons regulates sleep need in Drosophila. Science 324, 105–108 (2009).
Donlea, J. M., Ramanan, N., Silverman, N. & Shaw, P. J. Genetic rescue of functional senescence in synaptic and behavioral plasticity. Sleep 37, 1427–1437 (2014).
Rotwein, P. Regulation of gene expression by growth hormone. Mol. Cell. Endocrinol. 507, 110788 (2020).
Spiegel, K., Leproult, R. & Van Cauter, E. Impact of sleep debt on metabolic and endocrine function. Lancet 354, 1435–1439 (1999).
Jaffe, C. A. et al. Regulatory mechanisms of growth hormone secretion are sexually dimorphic. J. Clin. Invest. 102, 153–164 (1998).
Rodrigues, N. R. et al. Short-term sleep deprivation with exposure to nocturnal light alters mitochondrial bioenergetics in Drosophila. Free Radic. Biol. Med. 120, 395–406 (2018).
Andreazza, A. C. et al. Impairment of the mitochondrial electron transport chain due to sleep deprivation in mice. J. Psychiatr. Res. 44, 775–780 (2010).
Canty, T. G. Jr. et al. Oxidative stress induces NF-kappaB nuclear translocation without degradation of IkappaBalpha. Circulation 100, 361–364 (1999).
Irwin, M. R., Carrillo, C. & Olmstead, R. Sleep loss activates cellular markers of inflammation: sex differences. Brain Behav. Immun. 24, 54–57. https://doi.org/10.1016/j.bbi.2009.06.001 (2010).
Stavropoulos, N. & Young, M. W. insomniac and Cullin-3 regulate sleep and wakefulness in drosophila. Neuron 72, 964–976 (2011).
Huang, G. et al. SCCRO3 (DCUN1D3) antagonizes the neddylation and oncogenic activity of SCCRO (DCUN1D1). J. Biol. Chem. 289, 34728–34742 (2014).
Keuss, M. J. et al. Characterization of the mammalian family of DCN-type NEDD8 E3 ligases. J. Cell Sci. 129, 1441–1454 (2016).
Monda, J. K. et al. Structural conservation of distinctive N-terminal acetylation-dependent interactions across a family of mammalian NEDD8 ligation enzymes. Structure 21, 42–53 (2013).
Zhang, S. et al. DCUN1D3 activates SCFSKP2 ubiquitin E3 ligase activity and cell cycle progression under UV damage. Oncotarget 7, 58483–58491 (2016).
Pergola, P. E. et al. Bardoxolone methyl and kidney function in CKD with type 2 diabetes. N. Engl. J. Med. 365, 327–336 (2011).
De Zeeuw, D. et al. Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease. N. Engl. J. Med. 369, 2492–2503 (2013).
Tan, S. M. et al. Derivative of bardoxolone methyl, dh404, in an inverse dose-dependent manner lessens diabetes-associated atherosclerosis and improves diabetic kidney disease. Diabetes 63, 3091–3103 (2014).